CDCA7 Antikörper (AA 201-300)
Kurzübersicht für CDCA7 Antikörper (AA 201-300) (ABIN6988998)
Target
Alle CDCA7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-300
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Cow,Sheep,Pig,Rabbit
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CDCA7
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC-P 1:200-400
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CDCA7 (Cell Division Cycle Associated 7 (CDCA7))
-
Andere Bezeichnung
- CDCA7
-
Hintergrund
-
Synonyms: CDCA7, CDCA 7, CDCA-7, Cell division cycle associated 7, JPO1, CDCA7_HUMAN.
Background: Participates in MYC-mediated cell transformation, induces anchorage-independent growth and clonogenicity in lymphoblastoid cells. Insufficient to induce tumorigenicity when overexpressed but contributes to MYC-mediated tumorigenesis. May play a role as transcriptional regulator.
-
Gen-ID
- 83879
-
UniProt
- Q9BWT1
Target
-